For instance, oligodendrogliomas harboring IDH mutation alongside 1p/19q codeletion show a more promising prognosis, whereas glioblastomas with wild-type IDH are associated with a poorer outcome. The gene discussed is IDH2; the disease is oligodendroglioma.